🔬 Clinical Trials Program

Clinical Research

PharmaCare Global is committed to advancing medical research through rigorous clinical trials. Our trials are conducted at leading medical institutions worldwide, following the highest ethical standards and regulatory guidelines.

Active Studies

🟢 Recruiting

RELIEF-2025: Phase III Efficacy Study

A multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of MediRelief Pro in adults with chronic pain.

Trial ID: NCT05123456
Phase: Phase III
Enrollment: 2,500 participants
Locations: 45 sites globally
Start Date: March 2025
Est. Completion: December 2026
📋 Planned

RELIEF-PEDS: Pediatric Safety Study

Planned Phase II study to evaluate safety and pharmacokinetics in adolescents aged 12-17.

Trial ID: Pending
Phase: Phase II
Enrollment: 500 participants
Est. Start: Q2 2026

Completed Studies

✅ Completed

RELIEF-2023: Pivotal Efficacy Trial

Successfully completed Phase III trial demonstrating significant pain reduction. Results published in peer-reviewed journals.

Trial ID: NCT04987654
Participants: 1,850
Primary Endpoint: Met (p < 0.001)
Completed: August 2024
✅ Completed

RELIEF-2021: Long-term Safety Extension

52-week open-label extension study demonstrating sustained efficacy and safety profile.

Trial ID: NCT04555123
Participants: 890
Duration: 52 weeks
Completed: February 2023

📊 Trial Statistics

Total Participants

0

Research Sites

0

Countries

0